TCL Archive An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists. May 13, 2005
TCL Archive In Brief: DeVita, Seffrin Head Committee advising Feinstein On National Cancer Revision November 5, 1999
TCL Archive NCI Moves Ahead With Trials Database, Reporting Studies In Progress At Cancer Centers July 15, 2011
TCL Archive Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study January 28, 2011
TCL Archive DCT Board Approves Recompetition Of Clinical Trials, Other Contracts, New BNCT Grants October 28, 1988
